- Barrons.com
Insulet Points Its Insulin Pump at the Big Diabetes Market: Type 2
Automated pumps are already used by about 40% of those with the autoimmune version of diabetes, known as Type-1.
- Zacks
Novo Nordisk (NVO) to Invest $4.1B in Clayton Facility Expansion
Novo Nordisk (NVO) plans to invest $4.1 billion in order to expand its Clayton facility with a second manufacturing plant, boosting capacity for injectable treatments and creating 1,000 new jobs.
- Zacks
Is Eli Lilly (LLY) a Buy on Tirzepatide Success in Sleep Apnea?
Eli Lilly (LLY) files for the approval of tirzepatide to treat obstructive sleep apnea in adults with obesity in the United States. If approved, sales of the blockbuster drug will rise further.
